Abstract. We report the tomographic imaging of a photodynamic therapy (PDT) photosensitizer, 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH) in vivo with time-domain fluorescence diffuse optical tomography (TD-FDOT). Simultaneous reconstruction of fluorescence yield and lifetime of HPPH was performed before and after PDT. The methodology was validated in phantom experiments, and depth-resolved in vivo imaging was achieved through simultaneous three-dimensional (3-D) mappings of fluorescence yield and lifetime contrasts. The tomographic images of a human head-and-neck xenograft in a mouse confirmed the preferential uptake and retention of HPPH by the tumor 24-h post-injection. HPPH-mediated PDT induced significant changes in fluorescence yield and lifetime. This pilot study demonstrates that TD-FDOT may be a good imaging modality for assessing photosensitizer distributions in deep tissue during PDT monitoring.
Introduction
Photodynamic therapy (PDT) is a clinically attractive treatment option for eradicating early-stage cancers. [1] [2] [3] With high tumor avidity, the chlorin-based compound 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH) has been shown to be a potential photosenstizer for imaging and treatment. 4 Recent HPPH-oriented laboratory research and early-phase clinical studies at Roswell Park Cancer Institute (RPCI) have demonstrated that HPPH-mediated PDT is an effective treatment option for superficial cancers such as skin and head and neck lesions in the oral cavity. [4] [5] [6] [7] [8] The efficacy of PDT is largely dependent on the spatial distribution and temporal changes of the photosensitizer. [9] [10] [11] Fluorescence properties of photosensitizers can be utilized to assess the photosensitizer content. Due to its simplicity, fluorescence spectroscopy has been employed in many preclinical and clinical studies (see reviews in Refs. 9 and 12). However, fluorescence spectroscopy is not well suited for quantifying spatial heterogeneities of optical properties, especially when deeper and thicker tissue is being investigated. In recent years, noninvasive near-infrared fluorescence diffuse optical tomography (FDOT) technologies emerged as viable approaches for imaging heterogeneities in deep tissue. For example, FDOT has been utilized as quantitative imaging for the localization of fluorophores in deeply seated tumors, as well as for therapy monitoring. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] Among FDOT modalities, the time-domain (TD) modality provides superior sensitivity over continuous-wave FDOT and frequency-domain FDOT for detecting weak fluorescence signals. [33] [34] [35] It can quantify absolute concentration and depth of a fluorophore by analyzing time-of-flight measurements. [36] [37] [38] [39] [40] [41] In addition, TD-FDOT offers quantification of another imaging contrast: fluorescence lifetime. 14, [42] [43] [44] [45] [46] [47] [48] As an intrinsic property of a fluorophore, the fluorescence lifetime is independent of fluorescence signal intensity, allowing time domain to be a robust technique for tumor demarcation. 35, [49] [50] [51] [52] [53] Fluorescence lifetime may change in response to local molecular and cellular changes such as binding, polarity, pH value, and oxygenation status. 34, 54, 55 As such, changes in fluorophore lifetime can be potential noninvasive biomarkers for investigating and visualizing the local microvascular changes, photophysical processes, and photochemical reactions at molecular and cellular levels. [55] [56] [57] [58] [59] For example, microscopic TD imaging has been applied for studying photobleaching and lifetime dynamics of PDT photosensitizers in cells. 55, 56, 60, 61 In this paper, we report the application of TD-FDOT for 3-D reconstructions of the fluorescence yield and lifetime of the photosensitizer HPPH in vivo before and after PDT. We first describe a TD-FDOT system, which employs an ultra-short pulse laser, gated imaging, and time-delay techniques. We demonstrate the performance of the imaging system in resolving the fluorescence yield and lifetime of HPPH with phantom experiments. Then we show in vivo mouse imaging results. Further, we quantify the changes in these parameters due to PDT. Our imaging results show that the HPPH preferentially accumulated in the tumor, which allowed accurate localization of the tumor. In addition we show depth-resolved photobleaching and lifetime changes due to HPPH-mediated PDT. This study demonstrates the utility of the TD-FDOT system for monitoring PDT with fluorescence yield and lifetime contrasts. Figure 1 shows the schematic of our experimental TD-FDOT system. Planar transmission geometry was adopted to achieve large-area tissue sampling with the combination of a galvanometer scanner and a lens coupled charge-coupled device (CCD) camera. 15, 16, 42 A 660 nm pulsed laser (BHLP-660, Becker & Hickl GmbH) was used as the light source to match HPPH's absorption peak at 665 nm. 5 The laser has a pulse repetition rate of 50 MHz. The average optical power was set to ∼0.5 mW, and the full-width-at-half-maximum (FWHM) of the laser pulse was ∼120 ps. The spectrum of the collimated laser beam was first corrected with a bandpass filter (BPF) in front of the laser, and then the laser beam was focused on the front wall of the imaging chamber (W f in Fig. 1 ). The imaging chamber was sandwiched between two pieces of transparent, antireflection-coated glass, allowing an imaging volume of 80 mm × 80 mm × 18 mm. Homogenous optical matching fluid, prepared by mixing India ink, Intralipid suspension, and water, was poured into the tank to serve as the homogeneous image background for phantom and mice experiments. The emission signals from the rear wall (W r in Fig. 1 ) sequentially passed through an optical filter, a collimation lens set (AF NIKKOR 50 mm f/1.4D, Nikon), and a high-gain image intensifier (PicoStar HR-12, LaVision) and was captured by a highly sensitive CCD camera (12 bit, Imager QE, LaVision). The high-gain image intensifier worked in a time-gated, or a "comb" mode, as described previously. 42 Briefly, each laser pulse (pulse rate ¼ 50 MHz) synchronously produced a trigger signal, which served as a timing reference. This trigger opened a high-rate image intensifier (HRI) gate after a fixed time delays. Time delays can be set by a delay unit, and gate widths can be set by HRI. The intensifier boosts the signal originated from the object. The CCD camera collected the boosted optical signal and streams data into personal computer. The CCD camera exposure length determines the number of laser pulses that are integrated. As the pulsed laser had a repetition rate of 50 MHz, 5 × 10 7 images could be accumulated if the CCD acquisition time was 1 s. As the trigger signals were delayed incrementally, the combination of image intensifier and CCD camera can record a sequence of images, which reflects the time-resolved photon intensity. An ultra-sharp, narrow bandpass filter (FF01-720/13-25, Semrock) in front of the image intensifier rejected undesired excitation photons. The incident laser beam was steered in an XY raster pattern by a high-quality programmable galvanometer scanner (ProSeries-10, Cambridge Technology). The entire experimental system was automated under computer control through a data acquisition module (NI-DAQmx, PCI-6259, National Instruments) and a custom LabVIEW (Version 8.5, National Instruments) program.
Methods

Experimental TD-FDOT System
Data Acquisition
In order to acquire the time-resolved signals, the "comb" mode of the image intensifier was utilized. The gate width Δτ gate was set to be 0.8 ns. The delay of the temporal acquisition, τ delay ¼ N · Δτ delay , N ¼ ½1 : : : N d was set to be τ delay ¼ ½0; 0.8; 1.6; : : : ; 12 ns, where the incremental step Δτ delay ¼ 0.8 ns and N d is the number of delay steps. The bias voltage of the image intensifier V bias (configurable in ½200 : : : 850 V) was fixed at 670 V and the exposure time of the CCD, τ exp was optimized to avoid signal saturations. These system settings are similar to previous work 42, 62, 63 and were optimized empirically with considerations of CCD's dynamic range, gain of the image intensifier, dark noise, HPPH dose and lifetime, and the data-acquisition time. In addition, the images acquired by the CCD camera binned to 128 × 128 pixels to increase the signal-to-noise ratio.
For each imaging experiment, three types of data sets were acquired: intrinsic excitation, fluorescence emission, and leakage. The data set of intrinsic laser excitation φ ex , which characterizes the system response in the presence of the imaging objects, was acquired by mounting a neutral-density filter (OD2) in front of the image intensifier. The data set of fluorescence emission φ em was acquired in a similar way, but by replacing the OD2 filter with a 720 nm bandpass fluorescence filter. The data set of leakage signal φ lk , which accounted for the bleeding-through of excitation light through the fluorescence filter, was acquired in a similar way as fluorescence emission, but with no fluorescence object in the imaging chamber. 16, 42, 64, 65 The exposure time τ exp was 400 ms during excitation, emission, and leakage measurements. Figure 2 shows an example of a time-resolved excitation and emission data from a HPPH phantom experiment. The leakage signal was negligible (mean AE standard deviation of φ lk was less than 2% of mean AE deviation of φ em , data not shown) under these experimental settings and optical properties.
Image Reconstruction
The quantification of fluorescence yield and lifetime was based on the normalized Born approximation. 13, 15, 17, 64 By making use of self-calibrated data that divide the fluorescence measurements with corresponding excitation measurements, the normalized Born ratio works with analytical or numerical forward solvers and offers significant experimental advantages as it is independent of source strengths, detector gains, coupling efficiency to tissue. These advantages significantly simplify the image reconstruction. 16, 17, 64, 66 Such image reconstruction method was recently reported to resolve 50 ps lifetime changes with a similar instrumentation approach. 42 The acquired time-resolved data were first converted into frequency domain. The real and imaginary information were extracted for resolving the fluorescence yield and lifetime simultaneously. Any harmonic frequencies ranging from base frequency f base through maximum frequency f max ¼ N · f base can be utilized for image reconstruction, where integer N is the order of harmonics or the total time-delay steps. 42, 45 
Here Φ nB ½r sðiÞ ; r dðjÞ ; ω is the normalized Born ratio of emission photon density to excitation photon density. The weight matrix W ði;j∶kÞ accounts for the perturbation of fluorescence heterogeneities at voxel vðkÞ in response to the excitation at source position r sðiÞ and the emission at the detector position r dðjÞ . Φ em ½r sðiÞ ; r dðjÞ ; ω and Φ ex ½r sðiÞ ; r dðjÞ ; ω are temporal pointspread functions (TPSF) of emission φ em ½r sðiÞ ; r dðjÞ and excitation φ ex ½r sðiÞ ; r dðjÞ in Fourier domain, respectively. λ em and λ ex are excitation wavelength and the emission wavelength, respectively. ω ¼ 2πf base is the fundamental angular frequency, which can be determined by the temporal sampling interval of the experiment. G is a two-point Green's function in frequency domain, 42, 45 with an altered form in order to account for the slab boundary conditions, 67 S 0 is a calibration factor depending on the geometry and optical properties. 17 The unknown volumetric variable X k , which encompasses spatial variations of fluorescence yield η k and lifetime τ k , can be resolved by inverting the linear equation Φ nB ¼ W · X. As a straightforward solution to this linear equation, in which complex numbers involved, terms of Φ nB , W, and X are decomposed and rewritten as where Reð·Þ and Imð·Þ stands for real and imaginary parts of the corresponding quantities, respectively. In this study, the algebraic reconstruction technique (ART) was used to iteratively resolve X k and reconstruct images for both phantom and mouse data. 68 The 3-D mappings of fluorescence yield and lifetime can be achieved simultaneously by rearranging the volumetric vector
Phantom and In Vivo Imaging
The laser scanning pattern was set to be an 8 × 8 grid, giving a total of 64 source positions (blue "þ" in Fig. 3 ). The laser beam had a diameter of ∼0.3 mm when focused on the imaging tank and was assumed to be a point source. The point-to-point separation was 3 mm, giving a total scanning area of ∼24 mm × 24 mm. For mouse imaging, this scanning area could cover the tumor with some peripheral tissue. On the detection plane (Z ¼ 18 mm), we chose 64 pixels, which had identical X and Y positions as 64 source positions (red "circle" in In order to characterize the accuracy of the image reconstruction, especially the fluorophore's lifetime, we conducted another phantom experiment using a well-known fluorescence compound, Atto655 (93711, Sigma-Aldrich). We chose Atto655 because it has similar excitation and emission peaks (λ ex ¼ 665 nm, λ em ¼ 690 nm) and the same order of magnitude lifetime (1.9 ns in water), which allowed using similar experimental settings. The tube containing Atto655 (concentration ¼ 0.5 μM) in optical matching fluid was placed vertically on the position ðX; ZÞ ≈ ð4.0; 9.0Þ mm. The in vivo mouse imaging and PDT treatments in this study were performed in compliance with Roswell Park Cancer Institute Animal Study Committees' requirements. A male severe combined immunodeficiency (SCID) mouse (12 weeks old, weight 30 grams) was inoculated subcutaneously with human head and neck tumor tissue obtained from a patient during an ongoing clinical trial. 7 The tumor was planted on the right lateral flank of the mouse and grew up to a diameter of approximately 10 mm (Fig. 4) . The photosensitizer HPPH (3 μmol∕kg) was injected intravenously via tail vein 24-h before the imaging experiment and PDT treatment. To minimize motion artifacts during scanning, the mouse was anesthetized with ketamine (100 mg∕kg), xylazine (10 mg∕kg), and acepromazine (3 mg∕kg). The anesthetized mouse was secured in a holder to minimize motion and discomfort. The holder with the mouse was submerged into the matching fluid-filled tank. The optical properties of the matching fluid were identical to those of the matching fluid made for phantom experiments. The temperature of the matching fluid was kept around 35°C to prevent loss of body heat. The mouse's head was above the fluid for normal breathing and the mouse's eyes were lubricated with tear gel to avoid drying.
During the PDT laser treatment, the mouse remained in the imaging chamber while the optical matching fluid was removed. The tumor area plus a small peripheral margin (16 mm diameter spot size) was irradiated with 75 mW∕cm 2 of 665 nm light from an Argon pumped dye laser. The treatment took 10 min for a total dose of 45 Joules∕cm 2 , and a single imaging scan took ∼12 min. During the entire imaging and treatment period, the mouse was kept anesthetized. X and Y coronal images were reconstructed at these five depths. After image reconstruction, for the lifetime quantification we demarcated the object size by including any voxel with yield values of at least 30% of the maximum yield. 45 Based on the thresholded lifetime images, the mean lifetime within the HPPH target area is found to be ð6.39 AE 0.11Þ ns (mean AE standard deviation), which is within the range of published results. 69 From the HPPH images, the position of the tube axis was found to be ðX; ZÞ ¼ ð−4.0 AE 0.5; 9.0 AE 0.5Þ mm, which agrees with the real center position ðX; ZÞ ¼ ð−4.0AE 0.5; 9.0 AE 0.5Þ mm. Moreover, the mean lifetime of Atto655 was found to be ð1.86 AE 0.16Þ ns, which closely agrees with the standard value of 1.9 ns. Although we did not fully characterized the accuracy of our system in estimating lifetimes, a recent study by Nothdurft et al. 42 reported a 50 ps lifetime sensitivity using a similar system and reconstruction strategy.
In Vivo Mouse Imaging
The mouse imaging was reconstructed in a similar way as the phantom images. Figure 5(a) shows the picture of the mouse outlined by white curves and tumor position pointed by red arrow. Figure 5(b) shows the scanned and imaged tumor area and surrounding peripheral normal tissues. The area in the white square shows the laser scanning and image reconstruction areas. The tumor area, indicated by the red circle, was located approximately in the top-left quadrant. The same mouse was The photobleaching was found to be depth-dependent due to the propagation of the PDT irradiation photons. For example, fluorescence yield photobleaching was higher (∼20%) close to the detector plane (Z ¼ 13 mm) where PDT treatment light was administered. Fluence rate (and photobleaching) is highest close to the laser irradiation plane and decreases as the photons of treatment light propagate through tissue. Figure 6 shows the in vivo peak photobleaching varied from ∼20% (close to PDT illumination, Z ¼ 13 mm) to 8% (Z ¼ 5 mm, further than PDT light). These results verify that the TD-FDOT system can quantify changes in photosensitizer distributions at different depths.
At the PDT Center in our institute, usual treatment parameters of 75 mW∕cm 2 of fluence rate, 30 min of total treatment time, and 135 Joules∕cm 2 of total light dose are being used as an effective treatment. Thus due to time constraints, the dose given in our study was three times less than the usual dose. It is hard to compare the photobleaching amount with previous work since photobleaching is strongly dependent on available oxygen, vascular parameters such as blood flow and photosenstizer distribution in the tumor. This human head and neck xenograft model is recently developed in our institute from extracted patient tumor tissue, and it can be very different than other tumor models. It is a more realistic representation of large head and neck patient tumor masses with high interstitial pressure, low oxygen partial pressure, and less vasculature. 70 Less vasculature with low blood flow may result in low level of accumulated photosensitizer dose. Low oxygenation may result in inefficient photobleaching. 71 Moreover, photosensitizer distribution can be very different due to working mechanisms of the photosensitizer and tumor tissue types. Furthermore, one-to-one comparison to previous work requires imaging (preferably concurrently) a similar tissue volume. We are probing relatively deeper tissue volumes compared with typical superficial tissue being treated by PDT. In the near future experiments, we will image statistically significant number of animals and have opportunity to compare our in vivo results with the photosensitizer concentration obtained from excised tissues. Figure 7 shows the pre-PDT (blue lines) and post-PDT (red lines) histograms of the reconstructed images of HPPH lifetime, which clearly reveal that the HPPH lifetime increased after PDT. The mean lifetime increased from approximately ½4.3 AE 0.2 ns to ½5.0 AE 0.2 ns, resulting in a ∼16% of increase at the middle slice (Z ¼ 9 mm). As much as ∼700 ps change in lifetime is expected to be due to PDT-induced physiological changes such as changes in oxygenation (see Sud et al.) 57 and changes in the microenvironment of HPPH, such as changes in pH (see Scully et al. 55 and Sud et al.). 57 Lifetime increase is related to oxygenation decrease, which is highly possible since oxygen is being consumed during PDT. PDT can induce early blood flow increase (see Becker et al.) , 72 and interstitial fluid pressure decrease, resulting in a decrease in tumor acidity and increase in pH, which is related to lifetime increase. 57 Thus our results indicate that lifetime changes can potentially be employed for PDT monitoring.
It should be pointed out that although the image reconstruction was performed at a single frequency in this work, the Fourier-transformed time domain data has multifrequency information. The image reconstruction is expected to improve by using multifrequencies instead of a single frequency due to more information content [as long as high signal-to-noise ratio (SNR) is kept during the analysis]. For example, multifrequency data can allow extracting background optical properties more accurately and provide a priori information for more accurate reconstructions of fluorescence properties. 73 Thus timedomain techniques have advantages over single-frequencydomain methods. However, if single-frequency data is going to be used, frequency-domain methods can be more advantageous in in vivo studies since they can provide simpler and cheaper instruments and higher SNR.
Conclusion
In this work, we report the application of time-domain fluorescence diffuse optical tomography to image the PDT induced changes in fluorescence yield and lifetime in vivo. The image reconstruction results verified that the tumor-avid compound HPPH accumulated preferentially in the tumor 24-h post injection. The in vivo experiments showed the fluorescence yield of HPPH decreased and lifetime increased as a result of PDT. Our results highlight the potential that TD-FDOT can provide physiological and molecular level markers (such as fluorescence yield and lifetime) for monitoring PDT in preclinical and clinical settings.
